PRZ-METOCLOPRAMIDE 5 MG — DIN 02548747
METOCLOPRAMIDE HYDROCHLORIDE : 5 MG · PHARMARIS CANADA INC · TABLET · wholesale supply in Canada
Health Canada status: MARKETED
What is PRZ-METOCLOPRAMIDE?
PRZ-METOCLOPRAMIDE 5 MG contains METOCLOPRAMIDE HYDROCHLORIDE : 5 MG. It is listed in the Health Canada Drug Product Database under DIN 02548747, held by PHARMARIS CANADA INC, supplied as TABLET for ORAL administration. Health Canada currently lists it as marketed, status dated 30-Apr-2025. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
What is PRZ-METOCLOPRAMIDE used for?
PRZ - METOCLOPRAMIDE (metoclopramide hydrochloride) is indicated: • As an adjunct in the management of delayed gastric emptying associated with subacute and chronic gastritis or following vagotomy, pyloroplasty and other surgical procedures. • As an adjunct to facilitate small bowel intubation. • As an adjunct to facilitate gastroduodenal evacuation of barium meals and to improve radiological visualization of the gastroduodenal region in patients with gastric atonia, pylorospasm, spasm of the duodenal bulb, or with mechanical gastric outlet obstruction. Metoclopramide has also been shown to accelerate small bowel transit of the barium meal and to facilitate fluoroscopy of the terminal ileum. • To reduce postoperative vomiting induced by narcotics when used pre - operatively by the oral route.
Authorized indication as written in the Health Canada product monograph. For healthcare professionals and licensed purchasers; this is not medical advice.
How much does Metoclopramide cost around the world?
Metoclopramide is listed on 8 of the national price registers Nexara ingests. Each country publishes on a different basis, so those figures are not comparable with one another — or with a Canadian wholesale price.
What a market publishes matters more than the number it publishes. Australia publishes a ex-manufacturer; Greece publishes a producer price (ex-factory); Italy publishes a prezzo al pubblico (classe A). Comparing an ex-factory ceiling against a pharmacy public price tells you nothing about either, and comparing either against a Canadian landed cost tells you less.
| Market | Price basis published there | Brands | Packs listed | Range |
|---|---|---|---|---|
| United States | acquisition | 4 | 35 | USD███.██ |
| Morocco | PPV (public price) | 8 | 26 | MAD███.██ |
| Australia | ex-manufacturer | 7 | 23 | AUD███.██ |
| South Africa | single exit price | 12 | 17 | ZAR███.██ |
| Greece | producer price (ex-factory) | 6 | 6 | EUR███.██ |
| United Kingdom | hospital | 4 | 4 | GBP███.██ |
| Italy | prezzo al pubblico (classe A) | 2 | 2 | EUR███.██ |
| Lebanon | public price (USD, Decision 119/1) | 1 | 1 | USD███.██ |
114 pack listings across 44 brand entries and 8 price bases, refreshed 08 Sep 2026. Ranges span every Metoclopramide pack in that market, so a high figure is usually a larger pack rather than the same product.
Canada publishes no comparable public list price. For a delivered Canadian price on a licensed account, verify your licence — it takes about a minute.
Is there a generic Metoclopramide in Canada, and who makes it?
Every market authorization holder with a Canadian DIN for this molecule, and how many of their listings Health Canada currently shows as marketed.
15 holders have a Canadian DIN containing Metoclopramide, across 34 DINs, of which 10 are currently marketed. Marketed count is the number that matters: an approval that is not marketed cannot be bought.
| Market authorization holder | DINs | Marketed | Brand names | Position |
|---|---|---|---|---|
| PHARMASCIENCE INC | 7 | 3 | PMS-METOCLOPRAMIDE HYDROCHLORIDE INJECTION, PMS-METOCLOPRAMIDE HYDROCHLORIDE ORAL SOLUTION, PMS-METOCLOPRAMIDE HYDROCHLORIDE TABLETS, PMS-METOCLOPRAMIDE ORAL SOLUTION, PMS-METOCLOPRAMIDE TABLETS | Sourceable in Canada |
| PHARMARIS CANADA INC | 2 | 2 | PRZ-METOCLOPRAMIDE | Sourceable in Canada |
| MARCAN PHARMACEUTICALS INC | 2 | 1 | MAR-METOCLOPRAMIDE | Sourceable in Canada |
| BAXTER CORPORATION | 1 | 1 | METOCLOPRAMIDE HYDROCHLORIDE INJECTION | Sourceable in Canada |
| JAMP PHARMA CORPORATION | 1 | 1 | METOCLOPRAMIDE HYDROCHLORIDE INJECTION | Sourceable in Canada |
| OMEGA LABORATORIES LIMITED | 1 | 1 | METOCLOPRAMIDE INJECTION USP | Sourceable in Canada |
| SANDOZ CANADA INCORPORATED 4600 Rue Armand-Frappier Saint-Hubert Quebec Canada J3Z 1G5 | 1 | 1 | METOCLOPRAMIDE HYDROCHLORIDE INJECTION | Sourceable in Canada |
| AYERST LABORATORIES | 4 | 0 | REGLAN INJ 5MG/ML, REGLAN SYRUP 1MG/ML, REGLAN TAB 10MG, REGLAN TAB 5MG | No marketed DIN |
| WYETH-AYERST CANADA INC. | 4 | 0 | REGLAN INJECTABLE LIQ 5MG/ML, REGLAN SYR 1MG/ML, REGLAN TAB 10MG, REGLAN-5 TAB 5MG | No marketed DIN |
| HOECHST MARION ROUSSEL CANADA INC. | 3 | 0 | MAXERAN LIQ, MAXERAN-10 (10MG TABLET), MAXERAN-5 (5MG TABLET) | No marketed DIN |
| NU-PHARM INC | 2 | 0 | NU-METOCLOPRAMIDE-TAB 10MG, NU-METOCLOPRAMIDE-TAB 5MG | No marketed DIN |
| PRO DOC LIMITEE | 2 | 0 | METOCLOPRAMIDE TAB 10MG, METOCLOPRAMIDE TAB 5MG | No marketed DIN |
Health Canada’s Drug Product Database does not flag which listing is the originator and which are subsequent-entry products, so Nexara does not label them here. Interchangeability is determined provincially, not federally — confirm for your province before a formulary switch. Nexara can confirm which of these is actually obtainable, and on what lead time, per order.
How is it supplied and stored?
Pack configuration, storage class and the handling constraints that drive cold-chain planning. One DIN can cover more than one pack size, and the pack — not the DIN — is what gets priced, shipped and invoiced.
| Strength on the label | 5 MG |
|---|---|
| Dosage form | TABLET |
| Route | ORAL |
| Pack configuration (monograph) | HDPE bottles of 100 tablets |
| Storage | null |
Before an order line is unambiguous Nexara needs the strength, the pack size and the presentation.
Substance and classification
| Active substance | Metoclopramide |
|---|---|
| ATC code | A03FA01 |
| Biosimilar biologic | No |
Health Canada record and identifiers
The regulatory facts straight from the Drug Product Database, plus every identifier form Nexara accepts on a purchase order. A DIN written without its leading zeros is the commonest reason an order line fails to match.
| DIN (8-digit, as used in ordering) | 02548747 |
|---|---|
| DIN (unpadded, as printed on some documents) | 2548747 |
| Brand name | PRZ-METOCLOPRAMIDE |
| Generic / active ingredient | METOCLOPRAMIDE HYDROCHLORIDE : 5 MG |
| Market authorization holder | PHARMARIS CANADA INC |
| Health Canada schedule | Prescription |
| ATC code | A03FA01 |
| ATC anatomical main group | A — Alimentary tract and metabolism |
| ATC therapeutic subgroup | A03FA |
| Current status | MARKETED |
| Status date | 30-Apr-2025 |
| Status source | Live Health Canada DPD sync |
Verify on the primary sources
What can be used instead?
Alternatives on every axis a buyer actually considers — the same molecule in another presentation, the same class, an adjacent class, or a fixed-dose combination. Every row is led by the marketed DIN count, because that is what can be bought this week.
1 · Same molecule, other Canadian presentations
10 of 34 Canadian DINs for this molecule are currently marketed. Marketed products are listed first.
| Product | Strength | Form | Holder | Health Canada status | DIN |
|---|---|---|---|---|---|
| MAR-METOCLOPRAMIDE | 5 MG | TABLET | MARCAN PHARMACEUTICALS INC | MARKETED | 02517795 |
| METOCLOPRAMIDE HYDROCHLORIDE INJECTION | 5 MG | SOLUTION | JAMP PHARMA CORPORATION | MARKETED | 02537397 |
| METOCLOPRAMIDE HYDROCHLORIDE INJECTION | Strength | Liquid | SANDOZ CANADA INCORPORATED 4600 Rue Armand-Frappier Saint-Hubert Quebec Canada J3Z 1G5 | MARKETED | 02185431 |
| METOCLOPRAMIDE HYDROCHLORIDE INJECTION | 5 MG | SOLUTION | BAXTER CORPORATION | MARKETED | 02531747 |
| METOCLOPRAMIDE INJECTION USP | 5 MG | SOLUTION | OMEGA LABORATORIES LIMITED | MARKETED | 02243563 |
| PMS-METOCLOPRAMIDE HYDROCHLORIDE INJECTION | 5 MG | SOLUTION | PHARMASCIENCE INC | MARKETED | 02510790 |
| PMS-METOCLOPRAMIDE ORAL SOLUTION | 5 MG / 5 ML | SOLUTION | PHARMASCIENCE INC | MARKETED | 02230433 |
| PMS-METOCLOPRAMIDE TABLETS | 5 MG | TABLET | PHARMASCIENCE INC | MARKETED | 02230431 |
| PRZ-METOCLOPRAMIDE | 10 MG | TABLET | PHARMARIS CANADA INC | MARKETED | 02548755 |
| APO-METOCLOP TAB 10MG | 10 MG | TABLET | APOTEX INC | DORMANT | 00842834 |
2 · Same class — other molecules in ATC A03FA
| Molecule | Canadian brands | DINs | Marketed | Sourceable |
|---|---|---|---|---|
| Metoclopramide | APO-METOCLOP TAB 10MG · APO-METOCLOP TAB 5MG · MAR-METOCLOPRAMIDE · MAXERAN 5MG TAB · +23 more | 34 | 10 | Yes |
| Domperidone | APO-DOMPERIDONE · AVA-DOMPERIDONE · BIO-DOMPERIDONE · DOM-DOMPERIDONE · +16 more | 23 | 10 | Yes |
| Cisapride | PREPULSID SUS 1MG/ML · PREPULSID TAB 10MG · PREPULSID TAB 20MG · PREPULSID TAB 5MG | 4 | 0 | Not in Canada |
A molecule with zero marketed DINs cannot be sourced domestically, however many approvals it holds — if one of these sits on a formulary or in an older protocol, that is the line to check.
Not clinical advice. These tables describe what can be supplied in Canada, not what should be prescribed. Substitution within or across classes is a prescriber and pharmacist decision, and interchangeability is determined provincially.
What else is PRZ-METOCLOPRAMIDE called?
The same molecule, Metoclopramide, is registered under other names elsewhere. Buyers and prescribers searching from outside Canada — or working from a foreign prescription or tender document — often know it by one of these:
| Name | Script | Registered in |
|---|---|---|
| PRIMPERAN | Latin | Morocco |
| CLOPRAME | Latin | Morocco |
| Metoclopramide HCl Medsurge | Latin | Australia |
| METOCLOPRAMIDE INJECTION BP | Latin | Australia |
| APO-Metoclopramide | Latin | Australia |
| EMEXLON | Latin | Australia |
| Maxolon | Latin | Australia |
| METOCLOPRAMIDE-WGR | Latin | Australia |
| Pramin | Latin | Australia |
| Setin | Latin | South Africa |
| Maxolon t | Latin | South Africa |
| METAGLIZ | Latin | Morocco |
| PRAMIDOL | Latin | Morocco |
| Betaclopramide | Latin | South Africa |
| Clopamon-S | Latin | South Africa |
Names are taken from national medicine registers and published price lists. A product registered abroad is not authorized for sale in Canada unless it holds its own DIN; import is possible only through the routes Health Canada permits.
How can I get it?
Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address. Patients and unlicensed buyers are routed to a partner pharmacy.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Why is there no price on this page?
Nexara quotes a delivered Canadian price per order, against a verified licence. Foreign list prices are published on incompatible bases and are not a guide to what any buyer can obtain here, so this page shows which markets list the molecule and on what basis, and nothing more.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.